Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis

Published:2024-09-14 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Xie Yuting¹,Shi Sirong²³,Lv Weitong²,Wang Xinyu¹,Yue Lin¹,Deng Conghui¹,Wang Doudou¹,Han Jing⁴⁵,Ye Tinghong¹^ORCID,Lin Yunfeng²³^ORCID

Affiliation:

1. Laboratory of Gastrointestinal Cancer and Liver Disease, Department of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China

2. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

3. Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu 610041, China

4. Department of Respiratory and Critical Care Medicine, Guizhou Provincial People’s Hospital, Guiyang 550000, China

5. National Health Commission Key Laboratory for Diagnosis and Treatment of Pulmonary Immune Diseases, Guiyang 550000, China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c06598

Reference104 articles.

1. Pulmonary fibrosis: pathogenesis, etiology and regulation

2. Pulmonary fibrosis, part II: state-of-the-art patient management

3. Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives

4. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis

5. Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis